Trial Profile
Clinical Trials Insight: 700030445
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2008
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Adverse reactions; Therapeutic Use
- Sponsors DURECT Corporation
- 08 Feb 2008 New trial record.